NP47924 Cytokine Modulators
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-04b34f32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
13
Lots
7
7 awarded
Published
19 Mar 2025
Description
Supply of Cytokine Modulators to NHS Scotland.
Scope
- Reference
- ocds-h6vhtk-04b34f
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| API Sources | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 7 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 7 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Etanercept | £11.3m | cancelled |
| 2 | Infliximab IV | £5.6m | cancelled |
| 3 | Infliximab SC | £1.4m | cancelled |
| 4 | Methotrexate syringes (25mg/1 ml concentration) | £58k | cancelled |
| 5 | Methotrexate pens (25mg/1ml concentration) | £57k | cancelled |